Megamox /5 Susp 457 Mg 70 ml

Megamox /5 Susp 457 Mg 70 ml

Description:

Megamox 457 mg/5 ml suspension 70 ml is a prescription systemic antibiotic medicine containing amoxicillin and clavulanic acid, produced by Hikma Pharma. It belongs to the penicillin class combined with a beta-lactamase inhibitor, designed to treat a wide range of bacterial infections in adults and children. This oral suspension is typically used for respiratory, ear, sinus, skin, and urinary tract infections caused by beta-lactamase–producing bacteria that are resistant to amoxicillin alone.

Indications:

• Lower respiratory tract infections, including bronchitis and pneumonia, caused by beta-lactamase–producing isolates of Haemophilus influenzae and Moraxella catarrhalis.
• Acute bacterial otitis media (middle ear infection) caused by beta-lactamase–producing isolates of H. influenzae and M. catarrhalis.
• Acute bacterial sinusitis caused by beta-lactamase–producing isolates of H. influenzae and M. catarrhalis.
• Skin and skin structure infections caused by beta-lactamase–producing isolates of Staphylococcus aureus, Escherichia coli, and Klebsiella species.
• Urinary tract infections (UTIs) caused by beta-lactamase–producing isolates of E. coli, Klebsiella species, and Enterobacter species.
• Other susceptible bacterial infections as determined by a physician and based on culture and sensitivity testing where appropriate.

Active Ingredients / Key Components:

• Amoxicillin (as amoxicillin trihydrate) – part of a total 457 mg antibiotic combination per 5 ml oral suspension (exact amoxicillin mg per 5 ml not specified in available data).
• Clavulanic acid (as potassium clavulanate) – beta-lactamase inhibitor included within the 457 mg/5 ml combination (exact clavulanic acid mg per 5 ml not specified in available data).
• Pharmaceutical excipients – suspending agents, sweeteners, flavoring agents, and stabilizers (full excipient list and concentrations , please check the product leaflet or the manufacturer’s official website).

Dosage & Administration / How to Use:

• Megamox 457 mg/5 ml is for oral use only and should be used exactly as prescribed by a physician.
• Shake the bottle well before each use to ensure a uniform suspension.
• Measure the dose accurately using the provided measuring spoon or oral syringe; do not use household teaspoons.
• It is generally recommended to take the suspension at the start of a meal to improve absorption and reduce gastrointestinal side effects.
• Adult and pediatric doses depend on body weight, age, type, and severity of infection. Typical pediatric dosing is calculated in mg/kg/day of the amoxicillin component, divided into 2–3 doses per day, but the exact regimen must be determined by the doctor.
• Duration of treatment usually ranges from 5 to 14 days depending on the infection; do not stop treatment early even if symptoms improve, unless directed by your doctor.
• If a dose is missed, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed one.
• Do not use in patients with known allergy to amoxicillin, clavulanic acid, other penicillins, or any component of the formulation.

Clinical Benefits:

• Provides broad-spectrum antibacterial activity by combining amoxicillin with clavulanic acid to overcome resistance from beta-lactamase–producing bacteria.
• Effectively treats common respiratory infections such as bronchitis, pneumonia, sinusitis, and otitis media, helping to relieve symptoms like fever, cough, ear pain, and sinus pressure.
• Helps control and resolve skin and soft tissue infections, reducing redness, swelling, and pain caused by susceptible bacteria.
• Supports rapid improvement in urinary tract infections by targeting resistant Gram-negative organisms, aiding in relief of dysuria, frequency, and pelvic discomfort.

Warnings & Contraindications:

• Contraindicated in patients with a history of hypersensitivity (allergy) to amoxicillin, clavulanic acid, any penicillin, or any component of the product.
• Use with extreme caution in patients with a history of severe allergic reactions to other beta-lactam antibiotics (e.g., cephalosporins, carbapenems); cross-sensitivity may occur.
• Contraindicated in patients with a history of cholestatic jaundice or hepatic dysfunction associated with amoxicillin/clavulanate use.
• Monitor liver function in patients with pre-existing hepatic impairment or those receiving prolonged therapy.
• Use with caution in patients with renal impairment; dosage adjustment may be required by the physician.
• Antibiotic-associated colitis (including Clostridioides difficile–associated diarrhea) may occur; discontinue and seek medical advice if severe, persistent, or bloody diarrhea develops.
• May interact with other medications such as anticoagulants (e.g., warfarin), allopurinol, and methotrexate; inform your doctor about all medicines you are taking.
• Consult your doctor before use if pregnant or nursing. Amoxicillin/clavulanic acid is generally used in pregnancy only when clearly needed and under medical supervision.
• Consult your doctor before use if you have liver disease, kidney disease, a history of gastrointestinal disease (especially colitis), or known allergies.
• Not intended for viral infections such as the common cold or influenza.
• Keep out of reach of children.

Side Effects:

• Common side effects may include nausea, vomiting, diarrhea, abdominal discomfort, and mild skin rash.
• Oral or vaginal candidiasis (thrush) may occur due to alteration of normal flora.
• Less common side effects can include headache, dizziness, and changes in taste.
• Serious but rare side effects include severe allergic reactions (anaphylaxis), angioedema, severe skin reactions (e.g., Stevens–Johnson syndrome), cholestatic jaundice, hepatitis, and severe diarrhea suggestive of pseudomembranous colitis.
• Seek immediate medical attention if you experience difficulty breathing, swelling of the face or throat, severe skin rash, yellowing of the skin or eyes, persistent or bloody diarrhea, or unusual bruising or bleeding.

Storage Instructions:

Store the unopened dry powder in a cool, dry place away from direct sunlight and moisture. After reconstitution with water (if supplied as dry powder), store the prepared suspension in a refrigerator if recommended by the manufacturer and use within the period stated on the label (typically 7–10 days; exact duration not provided in available information). Do not freeze. Keep the bottle tightly closed and keep out of reach of children.

Specifications:

• Product type: Oral antibiotic medicine (systemic antibiotic).
• Strength: 457 mg/5 ml (combined amoxicillin + clavulanic acid; exact ratio not specified in available data).
• Volume: 70 ml oral suspension after reconstitution (approximate final volume as indicated in product name).
• Form: Oral suspension for systemic use.
• Intended use: Treatment of susceptible bacterial infections as prescribed by a healthcare professional.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.